Free Trial

Trupanion (NASDAQ:TRUP) Given New $30.00 Price Target at Cantor Fitzgerald

Trupanion logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Cantor Fitzgerald lowered Trupanion’s price target to $30 from $34 while maintaining a “neutral” rating, implying approximately 21.56% upside from the stock’s $24.68 opening price.
  • Analyst sentiment remains cautious: one analyst rates Trupanion a Buy and five rate it Hold, resulting in a consensus “Hold” rating and an average price target of $38.40.
  • Trupanion exceeded quarterly expectations, reporting $0.16 EPS versus the $0.11 estimate and $392.93 million in revenue, up 11.1% year over year. However, company insiders sold 13,046 shares worth about $380,162 during the last quarter.
  • MarketBeat previews top five stocks to own in November.

Trupanion (NASDAQ:TRUP - Get Free Report) had its price objective lowered by analysts at Cantor Fitzgerald from $34.00 to $30.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has a "neutral" rating on the financial services provider's stock. Cantor Fitzgerald's price target points to a potential upside of 21.56% from the company's current price.

A number of other brokerages have also issued reports on TRUP. Weiss Ratings upgraded Trupanion from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, September 29th. Piper Sandler lowered Trupanion from an "overweight" rating to a "neutral" rating and cut their price objective for the company from $45.00 to $32.00 in a research report on Wednesday, August 26th. Atlantic Securities set a $42.00 price target on Trupanion in a research report on Wednesday, July 15th. Zacks Research downgraded Trupanion from a "strong-buy" rating to a "hold" rating in a research report on Monday, August 24th. Finally, Stifel Nicolaus lifted their price objective on shares of Trupanion from $28.00 to $29.00 and gave the stock a "hold" rating in a research note on Thursday, August 20th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $38.40.

Read Our Latest Stock Analysis on Trupanion

Trupanion Stock Up 0.4%

TRUP stock opened at $24.68 on Wednesday. The business's 50-day moving average price is $26.89 and its 200-day moving average price is $25.51. The stock has a market cap of $1.08 billion, a P/E ratio of 46.57, a PEG ratio of 1.70 and a beta of 1.44. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. Trupanion has a twelve month low of $21.16 and a twelve month high of $46.98.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.05. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The company had revenue of $392.93 million during the quarter, compared to analyst estimates of $389.72 million. During the same period in the prior year, the firm posted $0.22 EPS. The firm's quarterly revenue was up 11.1% compared to the same quarter last year. On average, equities research analysts forecast that Trupanion will post 0.63 EPS for the current year.

Insider Activity

In other news, COO John Gallagher sold 3,604 shares of the company's stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $29.70, for a total value of $107,038.80. Following the completion of the sale, the chief operating officer owned 33,742 shares of the company's stock, valued at approximately $1,002,137.40. This represents a 9.65% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Fawwad Qureshi sold 6,111 shares of the stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $30.01, for a total transaction of $183,391.11. Following the transaction, the chief financial officer owned 4,230 shares in the company, valued at approximately $126,942.30. This represents a 59.09% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 13,046 shares of company stock worth $380,162. 5.58% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. BlackRock Inc. bought a new position in shares of Trupanion during the 2nd quarter worth approximately $134,774,000. Bank of America Corp DE purchased a new stake in Trupanion in the second quarter valued at $14,262,000. Renaissancere Holdings Ltd. acquired a new position in shares of Trupanion in the 2nd quarter valued at $6,514,510. Bank of New York Mellon Corp purchased a new position in Trupanion in the second quarter valued at $4,631,000. Finally, Polar Capital Holdings Plc raised its position in shares of Trupanion by 13.5% in the fourth quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider's stock worth $55,121,000 after acquiring an additional 175,000 shares during the period.

About Trupanion

(Get Free Report)

Trupanion, Inc is a pet insurance company that provides medical insurance for cats and dogs. Its coverage is designed to help pet owners manage eligible veterinary expenses, including treatment for accidents, illnesses and other covered medical conditions.

The company offers subscription-based insurance plans primarily through direct-to-consumer channels and partnerships with veterinary practices. Trupanion also provides tools intended to streamline claims processing and enable participating veterinarians to receive payments directly, reducing the need for pet owners to pay eligible costs upfront and seek reimbursement.

Founded in 2000, Trupanion is headquartered in Seattle, Washington.

Read More

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Trupanion Right Now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines